Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Cerebral Cortex (New York, N.Y. : 1991)|September 3, 2004
Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathwayEiichi Jodo, Yoshiaki Suzuki, Tadahiro Katayama, et al.The Journal of Infectious Diseases|August 6, 2004
Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infectionNaomi Sugaya, Hiroshi Kimura, Shinya Hara, et al.Journal of Medical Virology|January 19, 2006
Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosisJun-Ichi Kawada, Hiroshi Kimura, Yukiko Shibata, et al.Journal of Clinical Psychopharmacology|September 6, 2022
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia: Retrospective, A 4-Year Mirror-Image StudySho Horikoshi, Itaru Miura, Akihiro Mui, et al.Journal of Virology|September 11, 2009
Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteersYo Hoshino, Harutaka Katano, Ping Zou, et al.British Journal of Haematology|February 19, 2002
Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantationAyami Yoshimi, Ikuya Tsuge, Hiroe Namizaki, et al.Microbiology and Immunology|June 25, 2004
Comparison of real-time and nested PCR assays for detection of herpes simplex virus DNAJun-ichi Kawada, Hiroshi Kimura, Yoshinori Ito, et al.Clinical and Vaccine Immunology : CVI|January 9, 2009
Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assayPeter D Burbelo, Yo Hoshino, Hannah Leahy, et al.The Journal of Infectious Diseases|August 26, 2009
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigsYo Hoshino, Lesley Pesnicak, Kennichi C Dowdell, et al.Plos Pathogens|October 27, 2011
Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challengeJunji Sashihara, Yo Hoshino, J Jason Bowman, et al.Pageof 3